ProfileGDS4177 / 211059_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 74% 73% 73% 71% 70% 68% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated128.9374
GSM603099KU-812 non-treated122.573
GSM603098KCL-22 Imatinib-treated132.0373
GSM603097KCL-22 non-treated112.2471
GSM603102JURL-MK1 Imatinib-treated97.9670
GSM603101JURL-MK1 non-treated86.2268